Homburger advised Credit Suisse (Switzerland) Ltd. and Investec Bank plc as mandated lead arrangers as well as the original lenders with regard to all legal aspects of the financing transaction. The team was led by partner Jürg Frick (Financing and Investment Products – pictured) and included associates David Borer, Stefan Bindschedler and Daniel Junginger (all Financing and Investment Products) as well as partner Stefan Oesterhelt (Tax).
In a pro bono project for the Swiss National Working Group on Swiss Franc Reference Rates (NWG), Baker McKenzie prepared a Form of Amendment Agreement for Swiss law governed syndicated credit facility agreements using CHF
NLS Pharmaceutics priced a USD 20 million IPO of 4,819,277 units consisting of one common share and one warrant to purchase one common share which are immediately separable from the units and issued separately. The common shares
The team included Olivier Favre (pictured), Fabio Elsener and Daniel Reiniger (all Banking & Finance / Capital Markets) as well as Michael Nordin and Roland Wild (both Tax).
The team includes Olivier Stahler (Banking, pictured), David Ledermann and Clément Bouvier (Corporate/M&A).
The team included Lukas Wyss (Partner, Finance - pictured), Johannes A. Bürgi (Partner, Finance), Maurus Winzap (Partner, Tax), Roger Ammann (Managing Associate, Finance), Valentin Wiesner (Associate, Finance) and Viktoriya Chernaya (Trainee Lawyer, Finance).
The law firm advised on its CHF 525 m syndicated credit facilities linked to sustainability targets. The Homburger team was led by associate David Borer (pictured left) and partner Hansjürg Appenzeller (pictured right) (both Financing
Bratschi team consisted of Barbara Jecklin (pictured) and Thomas Peter.
The NKF team was led by partner Till Spillmann (pictured), working with senior associate Adrian Koller and junior associates Selim Lötscher and Reto Seiler (all Finance).
The team included Philippe Borens (pictured left), Shawn Richard Gregory (pictured right), Fabio Elsener (all Banking & Finance / Capital Markets), Lorenzo Olgiati and Pascal Hubli (both Corporate / M&A) and Michael Nordin and Roland Wild (both
